You just read:

Janssen Expands Body of Evidence for INVOKANA® (canagliflozin) with 18 New Data Presentations at American Diabetes Association's 76th Scientific Sessions®

News provided by

Janssen Pharmaceuticals, Inc.

Jun 06, 2016, 08:00 ET